Metalyse (tenecteplase) 8000 units (40 mg) and 10000 units (50 mg) powder and solvent for solution for injection: temporary supply shortage
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Metalyse
|
Active substance |
tenecteplase
|
Therapeutic area (MeSH) |
Myocardial Infarction
|
Procedure number |
EMEA/H/C/000306
|
Regulatory outcome |
Maintenance
|
DHPC type |
Medicine shortage
|
Human ATC code |
B01AD11
|
Dissemination date |
23/09/2022
|